BridgeMD
Clinical and economical efficiency and safety and inflammation parameter correlations study of conservative treatment of non-complicated acute appendicitis in 7 to 18 years old children.
EU CTIS ID: 2025-520496-19-00
What this study is testing
To perform a complex clinical and economical study in children with acute appendicitis, provide new criteria for early diagnosis of acute noncomplicated appendicitis and its conservative treatment, as well as evaluate cost-efficiency.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age: 7-18 years Dg. Primary acute non-complicated appendicitis ALVORADO score ≥ 7 Pain in right lower quadrant of abdomen Blood tests: C-reactive protein ≤ 10 mg/L *If performed: *Il-6 ≤ 39,2 pg/mL *Ultrasound - acute appendicitis signs
You likely can't join if
- Positive pregnancy test Diffuse peritonitis Previous abdominal surgery Use of antibiotic drugs in previous 7 days Inflammatory bowel disease Immunosuppresive condition
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.